Results 151 to 160 of about 2,595,852 (298)

Inflation of the journal impact factor. [PDF]

open access: yesBMJ Health Care Inform
Ziegler J   +4 more
europepmc   +1 more source

Nicotinamide N‐methyltransferase promotes drug resistance in lung cancer, as revealed by nascent proteomic profiling

open access: yesMolecular Oncology, EarlyView.
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou   +5 more
wiley   +1 more source

JMCC plus receives first impact factor. [PDF]

open access: yesJ Mol Cell Cardiol Plus
Pavlovic D, Gundry R.
europepmc   +1 more source

More evidence of Impact Factor Mania. [PDF]

open access: yesMicrobiol Spectr, 2023
Schloss PD, Cuomo CA.
europepmc   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

Moving Forward with an Impact Factor. [PDF]

open access: yesIndian Dermatol Online J, 2023
Seetharam KA.
europepmc   +1 more source

Impact of Cardiovascular Risk Factors and Inflammatory Status on Urinary 8-OHdG in Essential Hypertension [PDF]

open access: bronze, 2011
Esther Roselló‐Lletí   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy